Sylvain J Marchais
Overview
Explore the profile of Sylvain J Marchais including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
2058
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
London G, Marchais S, Guerin A, de Vernejoul M
J Am Soc Nephrol
. 2014 Sep;
26(2):476-83.
PMID: 25231881
An association between atherosclerosis and osteoporosis has been reported in several studies. This association could result from local intraosseous atherosclerosis and ischemia, which is shown by limb osteoporosis in patients...
2.
London G, Pannier B, Marchais S
Blood Purif
. 2013 Jan;
35(1-3):16-21.
PMID: 23343541
Background: Accelerated arterial aging and inadequate outward arterial remodeling are observed in end-stage renal disease (ESRD) patients. Whether these changes could be closely associated with arterial calcifications has never been...
3.
Guerin A, Pannier B, Metivier F, Marchais S, London G
Curr Opin Nephrol Hypertens
. 2008 Nov;
17(6):635-41.
PMID: 19031658
Purpose Of Review: To review the most recent publications concerning the pathophysiology and clinical impact of arterial stiffening in patients with chronic kidney disease and those with end-stage renal disease....
4.
London G, Marchais S, Guerin A, Boutouyrie P, Metivier F, de Vernejoul M
J Am Soc Nephrol
. 2008 May;
19(9):1827-35.
PMID: 18480316
An inverse relationship between arterial calcifications and bone activity has been documented in patients with ESRD. Calcium overload is associated with arterial calcification, which is associated with arterial stiffening. Whether...
5.
Guerin A, Pannier B, Marchais S, London G
Curr Hypertens Rep
. 2008 May;
10(2):107-11.
PMID: 18474176
Cardiovascular disease is a major cause of morbidity and mortality in patients with end-stage renal disease (ESRD). Macrovascular disease develops rapidly in ESRD patients and is responsible for the high...
6.
London G, Guerin A, Verbeke F, Pannier B, Boutouyrie P, Marchais S, et al.
J Am Soc Nephrol
. 2007 Jan;
18(2):613-20.
PMID: 17202417
In ESRD, arterial function is abnormal, characterized by decreased capacitive function (arterial stiffening) and reduced conduit function, shown by diminished flow-mediated dilation (FMD). The pathophysiology of these abnormalities is not...
7.
Guerin A, Pannier B, Marchais S, London G
Curr Opin Nephrol Hypertens
. 2006 Feb;
15(2):105-10.
PMID: 16481874
Purpose Of Review: Cardiovascular disease is a major factor in the high mortality of patients with end-stage renal disease, and this population is particularly appropriate to analyse the impact of...
8.
London G, Marchais S, Guerin A, Metivier F
Curr Opin Nephrol Hypertens
. 2005 Oct;
14(6):525-31.
PMID: 16205470
Purpose Of Review: Arterial calcification in chronic kidney disease (CKD) is associated with increased cardiovascular risk. The mechanisms responsible for arterial calcification include alterations of mineral metabolism and expression of...
9.
Pannier B, Guerin A, Marchais S, Safar M, London G
Hypertension
. 2005 Mar;
45(4):592-6.
PMID: 15753232
The aorta is the principal capacitive element of the arterial tree and its increased stiffness, determined by measurement of aortic pulse wave velocity (PWV), is a strong independent predictor of...
10.
London G, Marchais S, Guerin A, Pannier B
Clin Exp Hypertens
. 2005 Feb;
26(7-8):689-99.
PMID: 15702623
The ill effects of hypertension are usually attributed to a reduction in the caliber or the number of arterioles, resulting in an increase in total peripheral resistance (TPR). This definition...